Few people understand the costs and complexities of cancer better than Helen Parsons, a cancer survivorship researcher at the ...
Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter 2024 Earnings Conference Call. My name is Tawanda, and I will be your ...
Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...
Native Americans face the longest travel times, even after accounting for distances in rural areas, according to results of a ...
The firm will make its artificial intelligence-based Lunit SCOPE IO platform available to SITC member researchers.
Immunotherapy has shown a 27% reduction in mortality for patients with limited-stage small cell lung cancer, based on Phase ...
Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) ...
Scientists of the University Medical Center Göttingen (UMG) have identified new interactions between pancreatic cancer cells ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.